km.idaeo.ai · IDAEO 知識庫

🏛 本文属于主题馆「reports」 →

植骨粉会有后遗症吗？失败了会怎样？｜證據鏈

km 編輯部2026-08-13阅读约 25 分钟
#證據鏈#牙醫KM#台灣#補骨

本頁是〈植骨粉会有后遗症吗？失败了会怎样？〉的事實單元帳：每一條主張對應的來源、證據等級、地域與期間、原文引句與限制，逐條攤開。

植骨粉会有后遗症吗？失败了会怎样？｜證據鏈

F-Units（事实单元账）

  • F1｜confidence: 已验证｜basis: 同行评审（PMID 28938030）｜period: 检索至 2015-07，2018 刊出｜geo: universal｜span: 「The weighted complication rate of the overall soft tissue complications … was 16.8% (95% CI = 10.6% to 25.4%)」「soft tissue lesions were reported as early as 1 week and as late as 6 months」｜caveat: 为 GBR 软组织并发症加权率，非个人风险
  • F2｜confidence: 已验证｜basis: 同行评审（PMID 35048503）｜period: 检索至 2020-11，2022 刊出｜geo: universal｜span: 「incidence proportion of healing complications … 11.0%」「membrane exposure without suppuration, membrane exposure with suppuration, and with abscess formation … 8.7% … 0.7% … 0.5%」「RoM of vertical bone gained was 0.65 … and 0.62」「The RoM of vertical bone gained was 0.65 [95% CI = 0.47, 0.91] and 0.62 [95% CI = 0.45, 0.85] when membrane exposure without suppuration and abscess formation without membrane exposure occurred respectively, in comparison to uneventful healing.」「The site-level incidence proportion of membrane exposure without suppuration, membrane exposure with suppuration, and with abscess formation without membrane exposure was 8.7% [95% CI = 4.2, 14.2], 0.7% [95% CI = 0.0, 2.9], and 0.5% [95% CI = 0.0, 1.7], respectively.」｜caveat: 限垂直 GBR，位点层级
  • F3｜confidence: 已验证｜basis: 同行评审（PMID 30667522）｜period: 2019 刊出｜geo: universal｜span: 「complications rate of 47.3% for distraction osteogenesis, 4.18 mm and 12.1% for guided bone regeneration (GBR), and 3.46 mm and 23.9% for bone blocks」「although complications are common」｜caveat: 垂直骨增量情境
  • F4｜confidence: 已验证｜basis: 同行评审（PMID 35737681）｜period: 检索 1960-01 至 2021-06｜geo: universal｜span: 「Postoperative pain, swelling, and edema were widely reported」「sinus membrane perforation (SMP), wound dehiscence, graft exposure and failure, and sinusitis」「benign paroxysmal positional vertigo following TSFE was significant in certain selected studies」｜caveat: 74 篇、4,411 例上颌窦提升术
  • F5｜confidence: 已验证｜basis: 同行评审（PMID 34250560）｜period: 2008 至 2020-04 文献｜geo: universal｜span: 「survival rate of 97.68% … 98.88%」「The rate of Schneiderian membrane perforation … was 30.6%」「is not a risk factor for dental implant survival (p=0.229; …)」「A total of 1115 implants were placed under previously perforated and repaired membranes, obtaining a survival rate of 97.68%, while 2495 implants were placed below sinus membranes that were not damaged during surgery, obtaining a survival rate of 98.88%.」｜caveat: 限侧窗术式、修补后
  • F6｜confidence: 已验证｜basis: 同行评审（PMID 37752820）｜period: 2023 刊出｜geo: universal｜span: 「regeneration occurred in a predictable way」「several complications (including exposure, infection, and soft tissue dehiscence) were reported, which tend to be higher when using cross-linked collagen membranes」｜caveat: 网络荟萃分析，限同期种植体置入的 GBR
  • F7｜confidence: 已验证｜basis: 同行评审（PMID 29231263）｜period: 2018 刊出｜geo: universal｜span: 「moderate limitation in the 1st 48 hr post-surgery but little or none by day 3 or 4」「Mild to moderate pain and interference to daily activities were reported for the first 3 days requiring the use of NSAIDs only」「mild to moderate pain and restrictions to daily activities for 48-72 hr」「morbidity were greater with autogenous bone harvesting」｜caveat: 60 人前瞻性对照试验，上颌窦侧窗术式；个体差异大
  • F8｜confidence: 已验证｜basis: 同行评审（PMID 35056347）｜period: 2021 刊出，纳入 292 篇｜geo: universal｜span: 「implants in smokers had a higher failure risk in comparison with non-smokers (OR 2.402, p < 0.001)」「MBL mean difference (MD) between the groups was 0.580 mm」｜caveat: 观察性证据合并，非因果推论
  • F9｜confidence: 已验证｜basis: 同行评审（PMID 28332067）｜period: 2017 刊出｜geo: universal｜span: 「Postoperative infection and implant loss occurred in 8/121 sinuses (6.6%)」「Infection had the strongest correlation to preoperative chronic sinusitis (p = 0.007)」｜caveat: 单中心回顾性研究，109 人
  • F10｜confidence: 已验证｜basis: 同行评审（PMID 36807599）｜period: 检索至 2022-08｜geo: universal｜span: 「diabetic patients with dental implants and good glycaemic control have a significantly lower risk of peri-implantitis (odds ratio [OR] = 0.16」「risk of dental implant failure (or = 3.76; 95% ci: 1.50-9.45; …) appears to be greater under irregular or no SPC」｜caveat: 间接证据，作者注明证据局限
  • F11｜confidence: 已验证｜basis: 临床指南（PMID 35300956，AAOMS 2022 立场书）｜period: 2022 更新版｜geo: universal｜span: 「Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaws (MRONJ)」｜caveat: 本卡仅引用其存在与适用人群，不引用个别处置建议
  • F12｜confidence: 已验证｜basis: 同行评审（PMID 35472121）｜period: 2022 刊出｜geo: universal｜span: 「a protocol specific to the classification and management of d-PTFE membrane healing complications is required and is thus presented in this paper」｜caveat: 限 d-PTFE 膜材料，说明“暴露需要专业分类和处置”，而非自行处理
  • F13｜confidence: 已验证｜basis: 同行评审（PMID 37109671）｜period: 2023 刊出，12 篇 RCT｜geo: universal｜span: 「The routine use of prophylactic antibiotics to prevent infection in dental implant placement was found to be not sufficiently effective to justify routine use」「Clear clinical assessment pathways … are required」｜caveat: 属临床决策层面，患者不得据此自行停药
  • F14｜confidence: 已验证｜basis: 同行评审（PMID 30155575）｜period: 2019 刊出｜geo: universal｜span: 「The interruption of antithrombotics prior to tooth removal because of the fear of bleeding or following postoperative bleeding increases the risk of thromboembolic events」「The investigated haemostatics included gauze pressure」｜caveat: 原研究情境为拔牙，本卡仅引用止血措施类别与停药风险
  • F15｜confidence: 已验证｜basis: 同行评审（PMID 34074573）｜period: 1997 至 2013 全国登记，2022 刊出｜geo: universal｜span: 「other implant-related complications (infection, implant malposition, lack of bone at implant site, mechanical damage, or failed osseointegration)」｜caveat: 芬兰理赔登记数据，仅用于“神经损伤属已知并发症类别”
  • F16｜confidence: 已验证（2026-08-05 复验，同 #9 卡锚 C2）｜basis: 法律｜period: 现行条文｜geo: TW｜span: 《全民健康保險法》第 51 條「十一、義齒、義眼、眼鏡、助聽器、輪椅、拐杖及其他非具積極治療性之裝具。」｜caveat: 个别给付以适用的健保条款与健保署现行公告为准，本卡不作给付判定
  • F17｜confidence: 已验证（2026-08-05）｜basis: 法律｜period: 现行条文｜geo: TW｜span: 《醫療法》第 63 條「醫療機構實施手術，應向病人或其法定代理人、配偶、親屬或關係人說明手術原因、手術成功率或可能發生之併發症及危險，並經其同意，簽具手術同意書及麻醉同意書，始得為之。」｜caveat: 条文引述，非法律意见
  • F18｜confidence: 已验证（2026-08-05）｜basis: 法律｜period: 现行条文｜geo: TW｜span: 《醫療法》第 81 條「醫療機構診治病人時，應向病人或其法定代理人、配偶、親屬或關係人告知其病情、治療方針、處置、用藥、預後情形及可能之不良反應。」｜caveat: 条文引述，非法律意见
  • F19｜confidence: 已验证（2026-08-05）｜basis: 官方声明｜period: 数据集现状｜geo: TW｜span: 政府資料開放平臺資料集「臺北市醫療收費標準」，提供機關臺北市政府衛生局｜caveat: 单一县市例证；其他县市页面在放量前须逐一补验；同 #9 卡锚 C3 家族
  • F20｜confidence: 已验证（入口可及，2026-08-05 复验 HTTP 200）｜basis: 官方声明｜period: 入口现状｜geo: TW｜span: 健保署醫材比價網入口 info.nhi.gov.tw/INAE2000/INAE2010S01｜caveat: 页面内容由 JS 动态加载，curl 无法逐字比对；名称与收录范围依 #9 卡锚 C4 查证；骨移植材料是否为可查品项，发布前需补做实测；2026-08-05 OP 实测更正：该网两条类别路径均不含牙科，无法由此查证骨移植材料
  • F21｜confidence: 已验证｜basis: 内部数据｜period: 2025-03 至 2026-08 GSC｜geo: TW｜span: backlog #28「補骨粉後遺症」等 7 詞項合計曝光 121,073，跨 4 站｜caveat: 曝光为属性级数字，非去重流量
  • F22｜confidence: 结构性整理（编辑框架，非外部事实主张）｜basis: 编辑框架｜period: 2026-08-05｜geo: universal｜span: 「文獻中廣泛報告的反應／該安排回診／該盡快就醫」三級分辨框架與「一天比一天輕」的走勢判斷，為本站依 F1 至 F15 文獻整理的溝通用架構｜caveat: 非诊断工具，不取代临床判断

来源清单

取用日期均为 2026-08-05；PubMed 条目以 E-utilities efetch 取得摘要原文，并逐条实测条目页回应 200。

  1. Lim G, et al. Wound Healing Complications Following Guided Bone Regeneration for Ridge Augmentation: A Systematic Review and Meta-Analysis. Int J Oral Maxillofac Implants. 2018;33(1):41-50. PMID 28938030
  2. Tay JRH, et al. Healing complications and their detrimental effects on bone gain in vertical-guided bone regeneration: A systematic review and meta-analysis. Clin Implant Dent Relat Res. 2022;24(1):43-71. PMID 35048503
  3. Urban IA, et al. Effectiveness of vertical ridge augmentation interventions: A systematic review and meta-analysis. J Clin Periodontol. 2019;46 Suppl 21:319-339. PMID 30667522
  4. Hsu YT, et al. Complications of sinus floor elevation procedure and management strategies: A systematic review. Clin Implant Dent Relat Res. 2022;24(6):740-765. PMID 35737681
  5. Díaz-Olivares LA, et al. Management of Schneiderian membrane perforations during maxillary sinus floor augmentation with lateral approach in relation to subsequent implant survival rates: a systematic review and meta-analysis. Int J Implant Dent. 2021;7(1):91. PMID 34250560
  6. Calciolari E, et al. Efficacy of biomaterials for lateral bone augmentation performed with guided bone regeneration. A network meta-analysis. Periodontol 2000. 2023;93(1):77-106. PMID 37752820
  7. Alayan J, Ivanovski S. A prospective controlled trial comparing xenograft/autogenous bone and collagen-stabilized xenograft for maxillary sinus augmentation. Clin Oral Implants Res. 2018;29(2):248-262. PMID 29231263
  8. Mustapha AD, et al. Smoking and Dental Implants: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021;58(1):39. PMID 35056347
  9. Kozuma A, et al. Preoperative chronic sinusitis as significant cause of postoperative infection and implant loss after sinus augmentation from a lateral approach. Oral Maxillofac Surg. 2017;21(2):193-200. PMID 28332067
  10. Carra MC, et al. Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis. J Clin Periodontol. 2023;50 Suppl 26:77-112. PMID 36807599
  11. Ruggiero SL, et al. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. J Oral Maxillofac Surg. 2022;80(5):920-943. PMID 35300956
  12. Vroom MG, et al. Clinical Classification of Healing Complications and Management in Guided Bone Regeneration Procedures with a Nonresorbable d-PTFE Membrane. Int J Periodontics Restorative Dent. 2022;42(3):419-427. PMID 35472121
  13. Torof E, et al. Antibiotic Use in Dental Implant Procedures: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2023;59(4):713. PMID 37109671
  14. Ockerman A, et al. Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic review. Clin Oral Investig. 2019;23(4):1695-1708. PMID 30155575
  15. Pääsky E, et al. Are women more susceptible than men to iatrogenic inferior alveolar nerve injury in dental implant surgery? Int J Oral Maxillofac Surg. 2022;51(2):251-256. PMID 34074573
  16. 全民健康保險法 第 51 條（全國法規資料庫）
  17. 醫療法 第 63 條（全國法規資料庫）
  18. 醫療法 第 81 條（全國法規資料庫）
  19. 政府資料開放平臺：臺北市醫療收費標準（提供機關：臺北市政府衛生局）
  20. 衛生福利部中央健康保險署 醫材比價網（入口）
  21. 内部数据：`analysis/reports/km-dental-backlog.md` #28 附录（词×站×曝光逐笔可对账）
  22. 编辑框架：本站三级分辨结构（无外部来源，标示为结构性整理）

内部引用链

  • 费用怎么问、报价单怎么读：种植牙一颗到底多少钱？（KM-DENTAL-09）
  • “牙套”名称分流与费用组成：“牙套”要多少钱？（KM-DENTAL-08）
发布闸门提醒：本卡为 draft。在产生 zh-Hans／en／ja 三个译本前，不得进入 km_entries；在 F20 的骨移植材料品项收录范围尚未实测前，该句维持“查证管道”定位，不得改写为价格陈述。

FAQ

什么情况要尽快就医，不能等？
化脓或形成脓肿、明显感染征象、肿胀或疼痛不减反增、出血持续且加压后仍难以控制，或嘴唇、下巴或舌头持续麻木时，请尽快就医 [F2][F6][F7][F22][F14][F15]。
どんな時は速やかに受診すべきですか？ — 排膿または膿瘍の形成、明らかな感染徴候、腫れや痛みが軽くならずむしろ悪化すること、出血が続くか圧迫しても止まりにくいこと、または唇・あご・舌のしびれが続くときは、速やかに受診してください [F2][F6][F7][F22][F14][F15]。
When do I need prompt medical care rather than wait? — Pus or an abscess, clear signs of infection, swelling or pain that is not easing and instead is getting worse, bleeding that continues or remains difficult to control after pressure, or persistent numbness of the lip, chin, or tongue all warrant prompt medical care [F2][F6][F7][F22][F14][F15].
植骨粉“跑出来”是否代表失败？
**不一定。** 颗粒外露多与伤口裂开或覆盖膜暴露有关。系统评价将移植材料外露列为需要介入处理的并发症之一 [F4]，而膜暴露有专门的分类与处置流程，由医生按材料和程度判断 [F12]。文献显示，并发症会使骨增量减少（均值比 0.65 与 0.62）[F2]，但这和“整个疗程作废”是两回事；请复诊让医生评估，不要自行拔除外露物。
骨補填材が「出てきた」ことは失敗を意味しますか？ — **必ずしもそうではありません。** 粒子の露出は、創部離開またはバリア膜露出に関連することが多いです。系統的レビューでは、移植材料の露出を介入処置が必要になり得る合併症の一つに挙げ [F4]、膜露出には材料と程度に応じて医師が判断する専用の分類・処置の流れがあります [F12]。文献は、合併症により骨増量が減少すること（平均比 0.65 と 0.62）を示しています [F2]。ただし、これは治療全体が無効になることとは別です。受診して評価を受け、露出物を自分で取り除かないでください。
Does graft material “coming out” mean it has failed? — **Not necessarily.** Exposed particles are often related to wound dehiscence or barrier-membrane exposure. A systematic review lists graft exposure as a complication that may need intervention [F4], and membrane exposure has specific classification and management pathways that a clinician judges according to the material and extent [F12]. The literature shows that complications reduce bone gain (mean ratios 0.65 and 0.62) [F2], but that is different from saying the whole course of treatment has been voided. Return for an assessment; do not remove exposed material yourself.
肿胀要多久才会消？
**按照文献描述的一般时程，最初 48 小时较明显，到术后第 3 至 4 天，多数为轻微影响或没有影响。** 前瞻性对照试验记录的是术后 48 至 72 小时的轻至中度疼痛和日常活动限制 [F7]。实际恢复速度因人而异，须由牙医师评估。
腫れはどのくらいで引きますか？ — **文献が述べる一般的な経過では、最初の 48 時間がより目立ち、術後 3〜4 日には多くの人で軽微または影響なしになります。** 前向き対照試験が記録したのは、術後 48〜72 時間の軽度から中等度の痛みと日常活動制限です [F7]。実際の回復速度は人により異なり、歯科医師の評価が必要です。
How long will the swelling take to go away? — **In the general timeline described in the literature, it is more noticeable during the first 48 hours, and by postoperative day 3 or 4 it is little or no impact for most people.** The prospective controlled trial recorded mild-to-moderate pain and limitation of daily activities for 48 to 72 hours after surgery [F7]. Actual recovery speed varies by person and requires a dentist’s assessment.

来源锚定

引用本文

km 編輯部・《植骨粉会有后遗症吗？失败了会怎样？｜證據鏈》・IDAEO 知識庫・2026-08-13・https://km.idaeo.ai/post/reports/dental-bone-graft-complications-evidence

相关文章

更新 2026-08-13T14:17:05.115Z · server-rendered · four-language · IDAEO 知識庫